Seattle Genetics (SGEN) Resumes Trading; Shares Down 9%

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. ROST
5. BILL

6. WMT
7. ADI
8. MRK
9. MRNA
10. LOW

July 14, 2011 5:05 PM EDT

Price: $228.74 --0%

Overall Analyst Rating:
SELL (= Flat)

Seattle Genetics (Nasdaq: SGEN) has resumed trading and is down 9% after FDA advisory committee votes in favor of accelerated approval of ADCETRIS.

FDA, Trading Halts

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!